PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Midazolam hydrochloride (Buccolam) - Status epilepticus

PAD Profile : Midazolam hydrochloride (Buccolam) - Status epilepticus

Keywords :
midazolam oral solution, midazolam oromucosal solution, midazolam buccal, buccal midazolam
Brand Names Include :
Buccolam

Traffic Light Status

Status 1 of 3.

Status :
Blue
Important Preferred
Formulations :
  • Pre-filled oral syringe
Important Information :
Prescribe by BRAND. Buccolam is currently the preferred, lower-cost in patients over 3 months of age
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
CD
SA
NICE
Comments :
No comments returned.
Documents :

Status 2 of 3.

Status :
Red
Important
Important Information :
Unlicensed preparations / specials have a Red traffic light status - not for prescribing in primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
CD
Un
Comments :
No comments returned.
Documents :

Status 3 of 3.

Status :
Red
Important
Formulations :
  • Liquid
Important Information :
ASPH Paediatrics only - (high-cost) unlicensed midazolam liquid 12.5mg/5ml sugar free.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
CD
R
U
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
03 April 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Status Epilepticus in all age groups (over 3 months of age)

The Surrey Heartlands Area Prescribing Committee agreed that:

  • Buccolam (midazolam hydrochloride) and Epistatus (midazolam maleate) will be assigned a Blue traffic light status (no information sheet required) for all ages over 3 months of age when used for Status Epilepticus.
  • Buccolam and Epistatus should be prescribed by brand (in line with MHRA & NICE guidance) https://surreyccg.res-systems.net/PAD/Guidelines/Detail/5045
  • The least costly preparation should be used at the point of initiation (currently Buccolam - April 2024)

NOTE: the use of Buccolam and Epistatus in patients aged 18 years and over is off-label.

Unlicensed specials will be assigned a RED traffic light status.

Patients using unlicensed preparations should be reviewed for a potential switch to the licensed product following liaison with their specialist.

Associated BNF Codes

04. Central Nervous System
04.08.02. Drugs used in status epilepticus
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More